About the Symposium:
This engaging, case-based 1.5 CNE learning opportunity is intended for oncology nurses who care for multiple myeloma patients. Four highly experienced nurses will share take-home nurse and patient tools, along with the latest research, in the context of fast-paced patient case studies that emphasize shared decision making, symptom management, and nursing implications of the latest therapeutic regimens for newly diagnosed and relapsed myeloma.
The Satellite Symposium is being held at the Oncology Nursing Society’s 43rd Annual Congress.
Thursday, May 17, 2018
Program and Lunch
Washington Marriott Marquis
901 Massachusetts Ave. NW, Washington, DC 20001
Marquis Ballroom 6-10
Space is limited, so we suggest that you register as soon as possible!
If you need any assistance in registering for the event, please contact
Maya Ormsby at MO.NurseEducation@gmail.com
Statement of Educational Need:
The clinical treatment of multiple myeloma is continuing to evolve as the wealth of FDA-approved drugs are administered to patients in new combinations. With the availability of multiple therapeutic regimens, patient preference and shared decision making are increasingly important. Nurses play key roles in encouraging patients to actively manage their symptoms and participate in their health care decisions. Given these changes in multiple myeloma (MM) treatment and practice patterns, it is more essential than ever to strengthen nurses’ knowledge of symptom management for myeloma regimens, shared decision making and the latest diagnostic testing.
Learning Goal and Objectives:
The overarching learning objective for the program is to educate and provide practical recommendations to nurses for optimal management and care of myeloma patients.
- Identify common treatment regimens in newly diagnosed and relapsed multiple myeloma
- Apply best practices in management of MM patients receiving myeloma therapeutic regimens, including effective symptom management
- Express the key role nurses play in advocating for their MM patients and caregivers
- Identify the steps in shared decision making and strategies to support the patients input in therapeutic decisions
- Discuss survivorship care plans and practical tools for long-term management and care of MM patients
After an introduction to the multiple myeloma disease state and shared decision making, brief cases of multiple myeloma patients provide the framework for discussing:
- Nursing perspectives for new therapeutic regimens for newly diagnosed multiple myeloma and relapsed disease
- The nurses role in managing symptoms, adherence, shared decision-making and advocating for their patients
- Practical tools and best practice tips are interwoven with the patient case stories
This activity has been designed to meet the educational needs of oncology nurses that are involved in the care of patients with multiple myeloma in either community or academic settings.
Disclosure of Conflicts of Interest:
It is the policy of the Annenberg Center for Health Sciences at Eisenhower to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, the Annenberg Center identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by the Annenberg Center to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.
Annenberg Center for Health Sciences at Eisenhower is accredited as a provider of continuing nursing education by the American Nurses Credentialing Centers Commission on Accreditation.
A maximum of 1.5 contact hours may be earned for successful completion of this activity.
The Annenberg Center for Health Sciences at Eisenhower, the designated educational division within Eisenhower Health (EH), is nationally and regionally accredited through 10 separate accrediting bodies, including continuously since 1982 the Accreditation Council for Continuing Medical Education (ACCME). In July 2016, the ACCME awarded the Annenberg Center Accreditation with Commendation, which confers a 6-year term of accreditation. The Annenberg Center is also accredited to award continuing nursing education (CNE) by the American Nurses Credentialing Center (ANCC).
There is no fee for this educational activity.
Meeting space has been assigned to provide a Theater Presentation supported by International Myeloma Foundation during the Oncology Nursing Society’s (ONS) 43rd Annual Congress, May 17-20, 2018 in Washington, D.C. The Oncology Nursing Society’s assignment of meeting space does not imply product endorsement.
In accordance with accreditation requirements, this program will be certified through the joint providership of the Annenberg Center and IMF for ANCC contact hours.
This activity is supported by educational grants from Celgene Corporation, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, and Takeda Oncology, and educational funding donation provided by Amgen.